Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trial

Background:. Fear over side-effects is one of the main drivers of COVID-19 vaccine hesitancy. A large literature in the behavioral and communication sciences finds that how risks are framed and presented to individuals affects their judgments of its severity. However, it remains unknown whether such...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sudharsanan, Nikkil (VerfasserIn) , Favaretti, Caterina (VerfasserIn) , Hachaturyan, Violetta (VerfasserIn) , Bärnighausen, Till (VerfasserIn) , Vandormael, Alain (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Aug 16, 2022
In: eLife
Year: 2022, Jahrgang: 11, Pages: 1-19
ISSN:2050-084X
DOI:10.7554/eLife.78765
Online-Zugang:Verlag, Volltext: https://doi.org/10.7554/eLife.78765
Volltext
Verfasserangaben:Nikkil Sudharsanan, Caterina Favaretti, Violetta Hachaturyan, Till Bärnighausen, Alain Vandormael

MARC

LEADER 00000caa a2200000 c 4500
001 1819884317
003 DE-627
005 20230118140626.0
007 cr uuu---uuuuu
008 221025s2022 xx |||||o 00| ||eng c
024 7 |a 10.7554/eLife.78765  |2 doi 
035 |a (DE-627)1819884317 
035 |a (DE-599)KXP1819884317 
035 |a (OCoLC)1361693932 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sudharsanan, Nikkil  |e VerfasserIn  |0 (DE-588)1191848108  |0 (DE-627)1670317765  |4 aut 
245 1 0 |a Effects of side-effect risk framing strategies on COVID-19 vaccine intentions  |b a randomized controlled trial  |c Nikkil Sudharsanan, Caterina Favaretti, Violetta Hachaturyan, Till Bärnighausen, Alain Vandormael 
264 1 |c Aug 16, 2022 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.10.2022 
520 |a Background:. Fear over side-effects is one of the main drivers of COVID-19 vaccine hesitancy. A large literature in the behavioral and communication sciences finds that how risks are framed and presented to individuals affects their judgments of its severity. However, it remains unknown whether such framing changes can affect COVID-19 vaccine behavior and be deployed as policy solutions to reduce hesitancy. Methods:. We conducted a pre-registered randomized controlled trial among 8998 participants in the United States and the United Kingdom to examine the effects of different ways of framing and presenting vaccine side-effects on individuals’ willingness to get vaccinated and their perceptions of vaccine safety. Results:. Adding a descriptive risk label (‘very low risk’) next to the numerical side-effect and providing a comparison to motor-vehicle mortality increased participants’ willingness to take the COVID-19 vaccine by 3.0 percentage points (p=0.003) and 2.4 percentage points (p=0.049), respectively. These effects were independent and additive and combining both framing strategies increased willingness to receive the vaccine by 6.1 percentage points (p<0.001). Mechanistically, we find evidence that these framing effects operate by increasing individuals’ perceptions of how safe the vaccine is. Conclusions:. Low-cost side-effect framing strategies can meaningfully affect vaccine intentions at a population level. Funding:. Heidelberg Institute of Global Health. Clinical trial number:. German Clinical Trials Registry (#DRKS00025551). 
650 4 |a behavior change 
650 4 |a COVID-19 
650 4 |a nudges 
650 4 |a risk communication 
650 4 |a vaccine hesitancy 
700 1 |a Favaretti, Caterina  |e VerfasserIn  |0 (DE-588)1248932994  |0 (DE-627)1785221434  |4 aut 
700 1 |a Hachaturyan, Violetta  |e VerfasserIn  |0 (DE-588)1248932781  |0 (DE-627)1785221094  |4 aut 
700 1 |a Bärnighausen, Till  |d 1969-  |e VerfasserIn  |0 (DE-588)120262029  |0 (DE-627)080560512  |0 (DE-576)178470848  |4 aut 
700 1 |a Vandormael, Alain  |e VerfasserIn  |0 (DE-588)136635385  |0 (DE-627)584919492  |0 (DE-576)30112132X  |4 aut 
773 0 8 |i Enthalten in  |t eLife  |d Cambridge : eLife Sciences Publications, 2012  |g 11(2022), Artikel-ID e78765, Seite 1-19  |h Online-Ressource  |w (DE-627)728518384  |w (DE-600)2687154-3  |w (DE-576)372567576  |x 2050-084X  |7 nnas  |a Effects of side-effect risk framing strategies on COVID-19 vaccine intentions a randomized controlled trial 
773 1 8 |g volume:11  |g year:2022  |g elocationid:e78765  |g pages:1-19  |g extent:19  |a Effects of side-effect risk framing strategies on COVID-19 vaccine intentions a randomized controlled trial 
856 4 0 |u https://doi.org/10.7554/eLife.78765  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20221025 
993 |a Article 
994 |a 2022 
998 |g 136635385  |a Vandormael, Alain  |m 136635385:Vandormael, Alain  |d 910000  |d 912800  |e 910000PV136635385  |e 912800PV136635385  |k 0/910000/  |k 1/910000/912800/  |p 5  |y j 
998 |g 120262029  |a Bärnighausen, Till  |m 120262029:Bärnighausen, Till  |d 910000  |d 912800  |e 910000PB120262029  |e 912800PB120262029  |k 0/910000/  |k 1/910000/912800/  |p 4 
998 |g 1248932994  |a Favaretti, Caterina  |m 1248932994:Favaretti, Caterina  |p 2 
998 |g 1191848108  |a Sudharsanan, Nikkil  |m 1191848108:Sudharsanan, Nikkil  |d 910000  |d 912800  |e 910000PS1191848108  |e 912800PS1191848108  |k 0/910000/  |k 1/910000/912800/  |p 1  |x j 
999 |a KXP-PPN1819884317  |e 4201669106 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.7554/eLife.78765"],"eki":["1819884317"]},"recId":"1819884317","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"Aug 16, 2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Nikkil","display":"Sudharsanan, Nikkil","family":"Sudharsanan","role":"aut"},{"display":"Favaretti, Caterina","family":"Favaretti","role":"aut","given":"Caterina"},{"given":"Violetta","display":"Hachaturyan, Violetta","family":"Hachaturyan","role":"aut"},{"given":"Till","role":"aut","display":"Bärnighausen, Till","family":"Bärnighausen"},{"given":"Alain","role":"aut","display":"Vandormael, Alain","family":"Vandormael"}],"relHost":[{"part":{"pages":"1-19","volume":"11","text":"11(2022), Artikel-ID e78765, Seite 1-19","extent":"19","year":"2022"},"disp":"Effects of side-effect risk framing strategies on COVID-19 vaccine intentions a randomized controlled trialeLife","pubHistory":["1.2012 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"eLife journal"}],"recId":"728518384","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title":"eLife","title_sort":"eLife"}],"note":["Gesehen am 28.06.17"],"id":{"eki":["728518384"],"zdb":["2687154-3"],"issn":["2050-084X"]},"origin":[{"publisher":"eLife Sciences Publications","dateIssuedKey":"2012","publisherPlace":"Cambridge","dateIssuedDisp":"2012-"}]}],"title":[{"title_sort":"Effects of side-effect risk framing strategies on COVID-19 vaccine intentions","title":"Effects of side-effect risk framing strategies on COVID-19 vaccine intentions","subtitle":"a randomized controlled trial"}],"language":["eng"],"physDesc":[{"extent":"19 S."}],"name":{"displayForm":["Nikkil Sudharsanan, Caterina Favaretti, Violetta Hachaturyan, Till Bärnighausen, Alain Vandormael"]},"note":["Gesehen am 25.10.2022"]} 
SRT |a SUDHARSANAEFFECTSOFS1620